Skip to main content

Advertisement

Log in

Complications Following D3 Gastrectomy: Post Hoc Analysis of a Randomized Trial

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Introduction

A single institutional surgical trial for gastric cancer had demonstrated increased morbidity but not mortality. This report analyzes risk factors affecting morbidity.

Methods

Risk factors for morbidity in 221 patients treated with curative intent were evaluated in a prospective randomized trial comparing D1 and D3 surgery for curable gastric cancer.

Results

The surgeon’s experience after 25 nodal dissections had no influence on surgical or overall complications, nor did the patients’ co-morbidity (e.g., respiratory system disease, cardiac disease, diabetes mellitus). Distal pancreatectomy negatively affected surgical morbidity [relative risk (RR) 6.21, 95% confidence interval (CI) 1.869–20.626] and overall morbidity (RR 5.50, 95% CI 1.671–18.082). All of the patients with a distal pancreatectomy underwent concomitant splenectomy. Multivariate analysis found splenectomy and nodal dissection to be the only two independent risk factors adversely affecting operative morbidity. The RR of splenectomy for surgical complications was 4.19 (95% CI 1.327–13.208), and for overall complications it was 3.88 (95% CI 1.259–11.973). The RR of nodal dissection for surgical complications was 2.51 (95% CI 1.336–4.730), and for overall complications it was 1.93 (95% CI 1.149–3.255).

Conclusions

Splenectomy (with or without pancreatectomy) and nodal dissection are risk factors for operative morbidity but not mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Pisani P, Parkin DM, Bray F, et al. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999;83:18–29

    PubMed  CAS  Google Scholar 

  2. Taiwan Area: Death Rate of Ten Leading Sites of Malignant Neoplasms, Taiwan, Department of Health, Executive Yuan, 2000;54–62

  3. Wu CW, Lui WY. Current management of gastric cancer in Taiwan. Asian J Surg 2001;48:253–257

    Google Scholar 

  4. Cady B. Lymph node metastases: indicators, but not governors of survival. Arch Surg 1984;119:1067–1072

    PubMed  CAS  Google Scholar 

  5. Bonenkamp JJ, Songun I, Hermans J, et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995;345:745–748

    Article  PubMed  CAS  Google Scholar 

  6. Cuschieri A, Fayers P, Fielding J, et al. Post-operative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomized controlled surgical trial. Lancet 1996;347:995–999

    Article  PubMed  CAS  Google Scholar 

  7. Sasako M. Risk factors for surgical treatment in the Dutch gastric cancer trial. Br J Surg 1997;84:1567–1571

    Article  PubMed  CAS  Google Scholar 

  8. Smith JM, Shiu MH, Kelsey L, et al. Morbidity of radical lymphadenectomy in the curative resection of gastric carcinoma. Arch Surg 1991;126:1469–1473

    PubMed  CAS  Google Scholar 

  9. Roder JD, Bottcher K, Siewert JR, et al. Prognostic factors in gastric carcinoma: results of the German Gastric Carcinoma study. Cancer 1993;72:2089–2097

    PubMed  CAS  Google Scholar 

  10. Heslin MJ. Extended lymph node dissection in gastric cancer: if a benefit exists, can it ever be proven? Ann Surg Oncol 2000;7:715–716

    Article  PubMed  CAS  Google Scholar 

  11. Wu CW, Hsiung CA, Lo SS, et al. Randomized clinical study of morbidity after D1 and D3 surgery for gastric cancer. Br J Surg 2004;91:283–287

    Article  PubMed  CAS  Google Scholar 

  12. Japanese Research Society for Gastric Cancer. Japanese Classification of Gastric Carcinoma, 1st English edition, Tokyo, Kanehara, 1995

    Google Scholar 

  13. Wu CW, Hsieh MC, Lo SS, et al. Morbidity and mortality after radical gastrectomy for patients with carcinoma of the stomach. J Am Coll Surg 1995;181:26–32

    PubMed  CAS  Google Scholar 

  14. Lo SS, Wu CW, Shen KH, et al. Higher morbidity and mortality after combined total gastrectomy and pancreaticosplenectomy for gastric cancer. World J Surg 2002;26:678–682

    Article  PubMed  Google Scholar 

  15. Wu CW, Chen Y, Hsieh MJ, et al. Use of a modified Foley catheter for continuous irrigation of intra-abdominal abscess. Br J Surg 1992;79:1296

    PubMed  CAS  Google Scholar 

  16. Csendes A, Burdiles P, Rojas J, et al. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery 2002;131:401–407

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors thank Hui-Tzu Yu and Yurh-Ling Ho of the data center at the National Health Research Institutes and research nurse Li-Ting Shia for assistance with data collection and processing. This study was supported by the Division of Cancer Research, National Health Research Institutes, Taiwan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Chew-Wun Wu MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wu, CW., Chang, IS., Lo, Ss. et al. Complications Following D3 Gastrectomy: Post Hoc Analysis of a Randomized Trial. World J. Surg. 30, 12–16 (2006). https://doi.org/10.1007/s00268-005-7951-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-005-7951-5

Keywords

Navigation